APA (7th ed.) Citation

TY, L., RM, T. T. S., S, M., B, A., EA, P., KM, L., . . . K, J. (2008). Linking antibody Fc domain to endostatin significantly improves endostatin half-life and efficacy. Clinical cancer research : an official journal of the American Association for Cancer Research, 14(5), 1487. https://doi.org/10.1158/1078-0432.CCR-07-1530

Chicago Style (17th ed.) Citation

TY, Lee, Tjin Tham Sjin RM, Movahedi S, Ahmed B, Pravda EA, Lo KM, Gillies SD, Folkman J, and Javaherian K. "Linking Antibody Fc Domain to Endostatin Significantly Improves Endostatin Half-life and Efficacy." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 14, no. 5 (2008): 1487. https://doi.org/10.1158/1078-0432.CCR-07-1530.

MLA (9th ed.) Citation

TY, Lee, et al. "Linking Antibody Fc Domain to Endostatin Significantly Improves Endostatin Half-life and Efficacy." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 14, no. 5, 2008, p. 1487, https://doi.org/10.1158/1078-0432.CCR-07-1530.